Added to YB: 2025-09-15
Pitch date: 2025-09-12
RPTX [bullish]
Repare Therapeutics Inc.
+20.9%
current return
Author Info
Biotenic is a freelance L/S biotech investment analyst sharing investment theses. Sign up for the newsletter.
Company Info
Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States.
Market Cap
N/A
Pitch Price
$1.77
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
N/A
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Repare Therapeutics Inc. - $RPTX
RPTX: Strategic alts candidate trading at ~$2 valuation w/ asset sales completed, workforce reduction ongoing. Multiple POC readouts Q4 in combo basket study. $257M milestones + royalties from licensing deals provide CVR upside. Margin of safety from cash + potential headline pop from efficacy data.
Read full article (3 min)